Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
biotech
clinical trials
fda
boston blog main
san francisco blog main
boston
boston top stories
new york blog main
san diego blog main
deals
dyne therapeutics
investing
myotonic dystrophy type 1
national top stories
new enterprise associates
rare disease drugs
san diego top stories
startups
achaogen
adams street partners
akili interactive labs
akouos
antibiotics
astellas pharma
astellas pharmaceuticals
atlas venture
audentes therapeutics
avidity biosciences
bempedoic acid
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biotech ipos
black diamond therapeutics
bladder cancer
bluebird bio
blueprint medicines
bruce leuchter
california institute for biomedical research
What
drug
7
×
medicines
7
×
therapeutics
7
×
ipo
approved
company
developing
dyne
fda
genetic
muscle
rare
affects
ago
americans
announced
backs
bacteria
bets
biopharma
biotech
biotechs
black
brings
business
cancer
cholesterol
click
clinic
combo
companies
considering
data
date
diamond
digital
disease
diseases
disorders
dyne’s
Language
unset
Current search:
drug
×
therapeutics
×
medicines
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum